BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Iyer JK, Kalra M, Kaul A, Payton ME, Kaul R. Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis. World J Gastroenterol 2017; 23(37): 6802-6816 [PMID: 29085224 DOI: 10.3748/wjg.v23.i37.6802]
URL: https://www.wjgnet.com/1007-9327/full/v23/i37/6802.htm
Number Citing Articles
1
Bubu A. Banini, Arun J. Sanyal. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 143 doi: 10.1016/bs.acr.2020.11.001
2
Tamás Deli, Mónika Orosz, Attila Jakab. Hormone Replacement Therapy in Cancer Survivors – Review of the LiteraturePathology & Oncology Research 2020; 26(1): 63 doi: 10.1007/s12253-018-00569-x
3
Guanying Feng, Jingshu Cai, Yunchuanxiang Huang, Xianjun Zhu, Bo Gong, Zhenglin Yang, Chunhong Yan, Zhuowei Hu, Lu Yang, Ziyan Wang. G-Protein-Coupled Estrogen Receptor 1 Promotes Gender Disparities in Hepatocellular Carcinoma via Modulation of SIN1 and mTOR Complex 2 ActivityMolecular Cancer Research 2020; 18(12): 1863 doi: 10.1158/1541-7786.MCR-20-0173
4
Yanmeng Li, Anjian Xu, Siyu Jia, Jian Huang. Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma (Review)Oncology Letters 2019;  doi: 10.3892/ol.2019.10127
5
Carolin Czauderna, Darko Castven, Friederike L. Mahn, Jens U. Marquardt. Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer—from Tumor Development to Therapeutic ImplicationsCancers 2019; 11(8): 1053 doi: 10.3390/cancers11081053
6
Patrizia Burra, Debora Bizzaro, Anna Gonta, Sarah Shalaby, Martina Gambato, Maria Cristina Morelli, Silvia Trapani, Annarosa Floreani, Fabio Marra, Maurizia Rossana Brunetto, Gloria Taliani, Erica Villa. Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)Liver International 2021; 41(8): 1713 doi: 10.1111/liv.14943
7
Wentao Wang, Yaxun Guo, Jingtao Zhong, Qi Wang, Xin Wang, Honglong Wei, Jie Li, Peng Xiu. The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinomaScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-82058-x
8
Tarek Mohamed Kamal Motawi, Nermin Abdel Hamid Sadik, Dina Sabry, Nancy Nabil Shahin, Sally Atef Fahim. rs2267531, a promoter SNP within glypican-3 gene in the X chromosome, is associated with hepatocellular carcinoma in EgyptiansScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43376-3
9
Arkadi Shwartz, Wolfram Goessling, Chunyue Yin. Macrophages in Zebrafish Models of Liver DiseasesFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02840
10
Guorun Fan, Yaqin Tu, Cai Chen, Haiying Sun, Chidan Wan, Xiong Cai. DNA methylation biomarkers for hepatocellular carcinomaCancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0629-5
11
Junita Desouza, Sushama Gadkar, Dhanashree Jagtap, Geetanjali Sachdeva. Size, site, and signaling: Three attributes of estrogen receptorsBiomedical Research Journal 2019; 6(2): 37 doi: 10.4103/BMRJ.BMRJ_24_19
12
Meaghan Phipps, Alexandra Livanos, Averill Guo, Sydney Pomenti, Jonathan Yeh, Lara Dakhoul, Heather Burney, Carla Kettler, Hao Liu, Ethan Miller, Samer Gawrieh, Andrew deLemos, Andrew Scanga, Naga Chalasani, Julia Wattacheril. Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United StatesAmerican Journal of Gastroenterology 2020; 115(9): 1486 doi: 10.14309/ajg.0000000000000643
13
Rukaiya Bashir Hamidu, Divya M. Chalikonda, Hie-Won Hann. Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case SeriesVaccines 2021; 9(8): 838 doi: 10.3390/vaccines9080838
14
A. David Rodrigues. Drug Interactions Involving 17α‐Ethinylestradiol: Considerations Beyond Cytochrome P450 3A Induction and InhibitionClinical Pharmacology & Therapeutics 2021;  doi: 10.1002/cpt.2383
15
Devaraj Ezhilarasan. Critical role of estrogen in the progression of chronic liver diseasesHepatobiliary & Pancreatic Diseases International 2020; 19(5): 429 doi: 10.1016/j.hbpd.2020.03.011
16
Joseph M. Collins, Zhiguang Huo, Danxin Wang. ESR1 ChIP-Seq Identifies Distinct Ligand-Free ESR1 Genomic Binding Sites in Human Hepatocytes and Liver TissueInternational Journal of Molecular Sciences 2021; 22(3): 1461 doi: 10.3390/ijms22031461
17
Luis E. Soria-Jasso, Raquel Cariño-Cortés, Víctor Manuel Muñoz-Pérez, Elizabeth Pérez-Hernández, Nury Pérez-Hernández, Eduardo Fernández-Martínez. Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the LiverInternational Journal of Molecular Sciences 2019; 20(19): 4694 doi: 10.3390/ijms20194694
18
Kuo‐Kuan Chang, Lein‐Ray Mo, Chun‐Hsiang Wang, Chia‐Chi Hsieh, Hua‐Yin Hsu, Yi‐Chen Tseng, Yuan‐Tsung Tseng. Long‐term effects of hormone replacement therapy on hepatocellular carcinoma risk and overall survival rate in women with chronic hepatitis C: A population‐based cohort study in TaiwanAdvances in Digestive Medicine 2020;  doi: 10.1002/aid2.13250
19
Anna Ruggieri, Maria Cristina Gagliardi, Simona Anticoli. Sex-Dependent Outcome of Hepatitis B and C Viruses Infections: Synergy of Sex Hormones and Immune Responses?Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02302
20
Javeria Khalid, Mohammad Umar, Tofeeq Ur-Rehman, Mashhood Ali, Gul Majid Khan. Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapyInfectious Agents and Cancer 2020; 15(1) doi: 10.1186/s13027-020-00300-z
21
Yosr Hamdi, Ines Abdeljaoued-Tej, Afzal Ali Zatchi, Sonia Abdelhak, Samir Boubaker, Joel S. Brown, Alia Benkahla. Cancer in Africa: The Untold StoryFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.650117
22
Youngsic Jeon, Jeong Eun Yoo, Hyungjin Rhee, Young-Joo Kim, Gwang Il Kim, Taek Chung, Sarah Yoon, Boram Shin, Hyun Goo Woo, Young Nyun Park. YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behaviorExperimental & Molecular Medicine 2021; 53(6): 1055 doi: 10.1038/s12276-021-00639-2
23
Alisa A. Petkevich, Aleksandr A. Abramov, Vadim I. Pospelov, Natalya A. Malinina, Elena I. Kuhareva, Natalya V. Mazurchik, Olga I. Tarasova. Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancerOncotarget 2021; 12(17): 1697 doi: 10.18632/oncotarget.28036
24
Michael Darden, Geoffrey Parker, Dominique Monlezun, Edward Anderson, Joseph F. Buell. Race and Gender Disparity in the Surgical Management of Hepatocellular Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Program RegistryWorld Journal of Surgery 2021; 45(8): 2538 doi: 10.1007/s00268-021-06091-7
25
Olga A Sukocheva. Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?World Journal of Gastroenterology 2018; 24(1): 1-4 doi: 10.3748/wjg.v24.i1.1
26
Chao-Yu Chen, Ting-Yao Wang, Wei-Ming Chen, Kai-Hua Chen, Yao-Hsu Yang, Pau-Chung Chen, Vincent Chin-Hung Chen. Bilateral oophorectomy and the risk of hepatocellular carcinoma in women with hepatitis C: A population-based studyMaturitas 2021; 146: 11 doi: 10.1016/j.maturitas.2020.12.006
27
Sungryong Oh, Hee Jung Kwon, Joohee Jung. Estrogen exposure causes the progressive growth of SK-Hep1-derived tumor in ovariectomized miceToxicological Research 2021;  doi: 10.1007/s43188-021-00100-6
28
Hui Hua, Hongying Zhang, Qingbin Kong, Yangfu Jiang. Mechanisms for estrogen receptor expression in human cancerExperimental Hematology & Oncology 2018; 7(1) doi: 10.1186/s40164-018-0116-7